ASXL1 and acute myeloid leukemia: Interestingly, 5 out of 7 ASXL1-interacting proteins dysregulated in BOS blood were also differentially expressed in AML-ASXL1, and dysregulated in the same direction, supporting the possibility of shared pathogenic mechanisms, despite the different clinical presentations.